{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:49:58Z","timestamp":1791496198951,"version":"4.3.4"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"King Saud University, Riyadh, Saudi Arabia","award":["ORF-2025-350"],"award-info":[{"award-number":["ORF-2025-350"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-12084-6","type":"journal-article","created":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T11:55:52Z","timestamp":1754135752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Establishment of THTT derivatives as potential antileishmanial and anti-inflammatory agents through in vitro and in silico investigations"],"prefix":"10.1038","volume":"15","author":[{"given":"Sarah","family":"Sarwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehana","family":"Masood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huma","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haleema","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajaz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Sikandar","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasool","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho","family":"Soonmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazif","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,2]]},"reference":[{"key":"12084_CR1","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.3390\/ijerph20021093","volume":"20","author":"NE Ismail","year":"2023","unstructured":"Ismail, N. E., Jimam, N. S., Goh, K. W., Tan, C. S. & Ming, L. C. Economic burdens of uncomplicated malaria in primary health care (PHC) facilities of Plateau State, Nigeria: patients\u2019 perspectives. Int. J. Environ. Res. Public Health 20, 1093 (2023).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"12084_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/cmdc.201200355","volume":"8","author":"Y Li","year":"2013","unstructured":"Li, Y., Geng, J., Liu, Y., Yu, S. & Zhao, G. Thiadiazole\u2014a promising structure in medicinal chemistry. ChemMedChem 8, 27\u201341 (2013).","journal-title":"ChemMedChem"},{"key":"12084_CR3","first-page":"38","volume":"61","author":"G Pl\u0103cint\u0103","year":"2018","unstructured":"Pl\u0103cint\u0103, G. et al. Cutaneous leishmaniasis. Mold. Med. J. 61, 38\u201342 (2018).","journal-title":"Mold. Med. J."},{"key":"12084_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/biomedicines13010093","volume":"13","author":"S Sarwar","year":"2025","unstructured":"Sarwar, S. et al. Targeting cutaneous leishmaniasis with thiadiazine thione derivatives: An in vivo study of its anti-inflammatory, anti-pyretic, anti-nociceptive, and anti-sedative properties. Biomedicines 13, 93 (2025).","journal-title":"Biomedicines"},{"key":"12084_CR5","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.3390\/antiox11091819","volume":"11","author":"AS-Y Kong","year":"2022","unstructured":"Kong, A.S.-Y. et al. Anti-and pro-oxidant properties of essential oils against antimicrobial resistance. Antioxidants 11, 1819 (2022).","journal-title":"Antioxidants"},{"key":"12084_CR6","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"J Alvar","year":"2012","unstructured":"Alvar, J. et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE 7, e35671 (2012).","journal-title":"PLoS ONE"},{"key":"12084_CR7","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.35500\/jghs.2020.2.e3","volume":"2","author":"RG Wamai","year":"2020","unstructured":"Wamai, R. G., Kahn, J., McGloin, J. & Ziaggi, G. Visceral leishmaniasis: A global overview. J. Global Health Sci. 2, e3 (2020).","journal-title":"J. Global Health Sci."},{"key":"12084_CR8","doi-asserted-by":"publisher","first-page":"e0005739","DOI":"10.1371\/journal.pntd.0005739","volume":"11","author":"F Bailey","year":"2017","unstructured":"Bailey, F. et al. A new perspective on cutaneous leishmaniasis\u2014implications for global prevalence and burden of disease estimates. PLoS Negl. Trop. Dis. 11, e0005739 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"12084_CR9","first-page":"293","volume":"26","author":"H Goto","year":"2012","unstructured":"Goto, H. & Lindoso, J. A. L. Cutaneous and mucocutaneous leishmaniasis. Infect. Dis. Clin. 26, 293\u2013307 (2012).","journal-title":"Infect. Dis. Clin."},{"key":"12084_CR10","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","volume":"366","author":"HW Murray","year":"2005","unstructured":"Murray, H. W., Berman, J. D., Davies, C. R. & Saravia, N. G. Advances in leishmaniasis. The Lancet 366, 1561\u20131577 (2005).","journal-title":"The Lancet"},{"key":"12084_CR11","doi-asserted-by":"publisher","first-page":"e525","DOI":"10.1016\/j.ijid.2011.03.021","volume":"15","author":"TS Tiuman","year":"2011","unstructured":"Tiuman, T. S., Santos, A. O., Ueda-Nakamura, T., Dias Filho, B. P. & Nakamura, C. V. Recent advances in leishmaniasis treatment. Int. J. Infect. Dis. 15, e525\u2013e532 (2011).","journal-title":"Int. J. Infect. Dis."},{"key":"12084_CR12","doi-asserted-by":"crossref","unstructured":"Rodrigues, J. C. F., Godinho, J. L. P. & de Souza, W. Biology of human pathogenic trypanosomatids: Epidemiology, lifecycle and ultrastructure. Proteins Proteom. Leishmania Trypanos. 1\u201342 (2013).","DOI":"10.1007\/978-94-007-7305-9_1"},{"key":"12084_CR13","doi-asserted-by":"publisher","first-page":"513","DOI":"10.4269\/ajtmh.14-0259","volume":"92","author":"S Sundar","year":"2015","unstructured":"Sundar, S., Singh, A., Rai, M. & Chakravarty, J. Single-dose indigenous liposomal amphotericin B in the treatment of Indian visceral leishmaniasis: A phase 2 study. Am. J. Trop. Med. Hyg. 92, 513 (2015).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"12084_CR14","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1093\/jac\/dks275","volume":"67","author":"TP Dorlo","year":"2012","unstructured":"Dorlo, T. P., Balasegaram, M., Beijnen, J. H. & de Vries, P. J. Miltefosine: A review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis. J. Antimicrob. Chemother. 67, 2576\u20132597 (2012).","journal-title":"J. Antimicrob. Chemother."},{"key":"12084_CR15","doi-asserted-by":"publisher","first-page":"815023","DOI":"10.1155\/2015\/815023","volume":"2015","author":"JPB de Menezes","year":"2015","unstructured":"de Menezes, J. P. B., Guedes, C. E. S., Petersen, A. L. D. O. A., Fraga, D. B. M. & Veras, P. S. T. Advances in development of new treatment for leishmaniasis. BioMed Res. Int. 2015, 815023 (2015).","journal-title":"BioMed Res. Int."},{"key":"12084_CR16","doi-asserted-by":"publisher","first-page":"10369","DOI":"10.1021\/cr400552x","volume":"114","author":"H Hussain","year":"2014","unstructured":"Hussain, H., Al-Harrasi, A., Al-Rawahi, A., Green, I. R. & Gibbons, S. Fruitful decade for antileishmanial compounds from 2002 to late 2011. Chem. Rev. 114, 10369\u201310428 (2014).","journal-title":"Chem. Rev."},{"key":"12084_CR17","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/S0140-6736(02)09096-7","volume":"359","author":"P Trouiller","year":"2002","unstructured":"Trouiller, P. et al. Drug development for neglected diseases: A deficient market and a public-health policy failure. The Lancet 359, 2188\u20132194 (2002).","journal-title":"The Lancet"},{"key":"12084_CR18","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1590\/S0074-02761994000300027","volume":"89","author":"R Lainson","year":"1994","unstructured":"Lainson, R. et al. The dermal leishmaniases of Brazil, with special reference to the eco-epidemiology of the disease in Amazonia. Mem. Inst. Oswaldo Cruz 89, 435\u2013443 (1994).","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"12084_CR19","doi-asserted-by":"publisher","first-page":"e2999","DOI":"10.1371\/journal.pntd.0002999","volume":"8","author":"AC Coelho","year":"2014","unstructured":"Coelho, A. C., Trinconi, C. T., Costa, C. H. & Uliana, S. R. In vitro and in vivo miltefosine susceptibility of a Leishmania amazonensis isolate from a patient with diffuse cutaneous leishmaniasis. PLoS Negl. Trop. Dis. 8, e2999 (2014).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"12084_CR20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/20477724.2016.1232042","volume":"110","author":"N Maspi","year":"2016","unstructured":"Maspi, N., Abdoli, A. & Ghaffarifar, F. Pro-and anti-inflammatory cytokines in cutaneous leishmaniasis: A review. Pathog. Glob. Health 110, 247\u2013260 (2016).","journal-title":"Pathog. Glob. Health"},{"key":"12084_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40816-020-00207-7","volume":"6","author":"S Yesmin","year":"2020","unstructured":"Yesmin, S. et al. Membrane stabilization as a mechanism of the anti-inflammatory activity of ethanolic root extract of Choi (Piper chaba). Clin. Phytosci. 6, 1\u201310 (2020).","journal-title":"Clin. Phytosci."},{"key":"12084_CR22","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3390\/cancers15030901","volume":"15","author":"M Waqas","year":"2023","unstructured":"Waqas, M. et al. Multi-fold computational analysis to discover novel putative inhibitors of isethionate sulfite-lyase (isla) from bilophila wadsworthia: Combating colorectal cancer and inflammatory bowel diseases. Cancers 15, 901 (2023).","journal-title":"Cancers"},{"key":"12084_CR23","doi-asserted-by":"publisher","first-page":"105743","DOI":"10.1016\/j.compbiomed.2022.105743","volume":"147","author":"SA Halim","year":"2022","unstructured":"Halim, S. A. et al. Discovering novel inhibitors of P2Y12 receptor using structure-based virtual screening, molecular dynamics simulation and MMPBSA approaches. Comput. Biol. Med. 147, 105743 (2022).","journal-title":"Comput. Biol. Med."},{"key":"12084_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jpain.2006.10.004","volume":"8","author":"AA Khan","year":"2007","unstructured":"Khan, A. A., Iadarola, M., Yang, H.-Y.T. & Dionne, R. A. Expression of COX-1 and COX-2 in a clinical model of acute inflammation. J. Pain 8, 349\u2013354 (2007).","journal-title":"J. Pain"},{"key":"12084_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1517\/14622416.1.3.257","volume":"1","author":"MC Peitsch","year":"2000","unstructured":"Peitsch, M. C., Schwede, T. & Guex, N. Automated protein modelling-the proteome in 3D. Pharmacogenomics 1, 257\u2013266 (2000).","journal-title":"Pharmacogenomics"},{"key":"12084_CR26","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s11686-024-00899-8","volume":"69","author":"H Khan","year":"2024","unstructured":"Khan, H. et al. Identification of novel antileishmanial chemotypes by high-throughput virtual and in vitro screening. Acta Parasitol. 69, 1439\u20131457 (2024).","journal-title":"Acta Parasitol."},{"key":"12084_CR27","doi-asserted-by":"publisher","first-page":"e3367","DOI":"10.1371\/journal.pntd.0003367","volume":"8","author":"M Ghosh","year":"2014","unstructured":"Ghosh, M. et al. Leishmania donovani infection enhances lateral mobility of macrophage membrane protein which is reversed by liposomal cholesterol. PLoS Negl. Trop. Dis. 8, e3367 (2014).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"12084_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-016-1470-0","volume":"9","author":"C Yao","year":"2016","unstructured":"Yao, C. & Wilson, M. E. Dynamics of sterol synthesis during development of Leishmania spp. parasites to their virulent form. Parasites Vectors 9, 1\u201312 (2016).","journal-title":"Parasites Vectors"},{"key":"12084_CR29","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.ijbiomac.2018.08.125","volume":"120","author":"B Vakili","year":"2018","unstructured":"Vakili, B. et al. Immunoinformatics-aided design of a potential multi-epitope peptide vaccine against Leishmania infantum. Int. J. Biol. Macromol. 120, 1127\u20131139 (2018).","journal-title":"Int. J. Biol. Macromol."},{"key":"12084_CR30","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/j.ejmech.2010.01.030","volume":"45","author":"M El Shehry","year":"2010","unstructured":"El Shehry, M., Abu-Hashem, A. & El-Telbani, E. Synthesis of 3-((2, 4-dichlorophenoxy) methyl)-1, 2, 4-triazolo (thiadiazoles and thiadiazines) as anti-inflammatory and molluscicidal agents. Eur. J. Med. Chem. 45, 1906\u20131911 (2010).","journal-title":"Eur. J. Med. Chem."},{"key":"12084_CR31","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s11030-018-9839-y","volume":"22","author":"L Kang","year":"2018","unstructured":"Kang, L. et al. Structure\u2013activity relationship investigation of coumarin\u2013chalcone hybrids with diverse side-chains as acetylcholinesterase and butyrylcholinesterase inhibitors. Mol. Divers. 22, 893\u2013906 (2018).","journal-title":"Mol. Divers."},{"key":"12084_CR32","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1080\/13880209.2017.1296000","volume":"55","author":"E Avulo\u011flu-Y\u0131lmaz","year":"2017","unstructured":"Avulo\u011flu-Y\u0131lmaz, E., Y\u00fczba\u015f\u0131o\u011flu, D., \u00d6z\u00e7elik, A. B., Ersan, S. & \u00dcnal, F. Evaluation of genotoxic effects of 3-methyl-5-(4-carboxycyclohexylmethyl)-tetrahydro-2H-1, 3, 5-thiadiazine-2-thione on human peripheral lymphocytes. Pharm. Biol. 55, 1228\u20131233 (2017).","journal-title":"Pharm. Biol."},{"key":"12084_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/1874104501105010051","volume":"5","author":"JC Bermello","year":"2011","unstructured":"Bermello, J. C., Pi\u00f1eiro, R. P., Fidalgo, L. M., Cabrera, H. R. & Navarro, M. S. Thiadiazine derivatives as antiprotozoal new drugs. Open Med. Chem. J. 5, 51 (2011).","journal-title":"Open Med. Chem. J."},{"key":"12084_CR34","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2174\/1570180819666220922103109","volume":"21","author":"MT Muhammed","year":"2024","unstructured":"Muhammed, M. T. & Aki-Yalcin, E. Molecular docking: principles, advances, and its applications in drug discovery. Lett. Drug Des. Discov. 21, 480\u2013495 (2024).","journal-title":"Lett. Drug Des. Discov."},{"key":"12084_CR35","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.2174\/1568026623666230623145802","volume":"23","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Recent advances in computer-aided virtual screening and docking optimization for aptamer. Curr. Top. Med. Chem. 23, 1985\u20132000 (2023).","journal-title":"Curr. Top. Med. Chem."},{"key":"12084_CR36","first-page":"132","volume":"39","author":"A Wadood","year":"2017","unstructured":"Wadood, A. et al. Structure-based development of new and potent inhibitors of PIM kinases: A computational study. J. Chem. Soc. Pak. 39, 132 (2017).","journal-title":"J. Chem. Soc. Pak."},{"key":"12084_CR37","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1021\/acschemneuro.0c00519","volume":"12","author":"M Riaz","year":"2021","unstructured":"Riaz, M. et al. Predicting multi-interfacial binding mechanisms of NLRP3 and ASC pyrin domains in inflammasome activation. ACS Chem. Neurosci. 12, 603\u2013612 (2021).","journal-title":"ACS Chem. Neurosci."},{"key":"12084_CR38","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1021\/jm900185q","volume":"52","author":"P Baiocco","year":"2009","unstructured":"Baiocco, P., Colotti, G., Franceschini, S. & Ilari, A. Molecular basis of antimony treatment in leishmaniasis. J. Med. Chem. 52, 2603\u20132612 (2009).","journal-title":"J. Med. Chem."},{"key":"12084_CR39","doi-asserted-by":"publisher","first-page":"17672","DOI":"10.1074\/jbc.M801850200","volume":"283","author":"PK Fyfe","year":"2008","unstructured":"Fyfe, P. K., Oza, S. L., Fairlamb, A. H. & Hunter, W. N. Leishmania trypanothione synthetase-amidase structure reveals a basis for regulation of conflicting synthetic and hydrolytic activities. J. Biol. Chem. 283, 17672\u201317680 (2008).","journal-title":"J. Biol. Chem."},{"key":"12084_CR40","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/S0969-2126(98)00104-X","volume":"6","author":"E Schlagenhauf","year":"1998","unstructured":"Schlagenhauf, E., Etges, R. & Metcalf, P. The crystal structure of the Leishmania major surface proteinase leishmanolysin (gp63). Structure 6, 1035\u20131046 (1998).","journal-title":"Structure"},{"key":"12084_CR41","doi-asserted-by":"crossref","unstructured":"Khan, H. et al. Investigating the role of Sterol C24-Methyl transferase mutation on drug resistance in leishmaniasis and identifying potential inhibitors. J. Biomol. Struct. Dyn. 1\u201314 (2023).","DOI":"10.1080\/07391102.2023.2256879"},{"key":"12084_CR42","doi-asserted-by":"publisher","first-page":"4312","DOI":"10.1038\/s41598-021-83438-z","volume":"11","author":"M Miciaccia","year":"2021","unstructured":"Miciaccia, M. et al. Three-dimensional structure of human cyclooxygenase (h COX)-1. Sci. Rep. 11, 4312 (2021).","journal-title":"Sci. Rep."},{"key":"12084_CR43","doi-asserted-by":"publisher","first-page":"15069","DOI":"10.1074\/jbc.M116.725713","volume":"291","author":"BJ Orlando","year":"2016","unstructured":"Orlando, B. J. & Malkowski, M. G. Substrate-selective inhibition of cyclooxygeanse-2 by fenamic acid derivatives is dependent on peroxide tone. J. Biol. Chem. 291, 15069\u201315081 (2016).","journal-title":"J. Biol. Chem."},{"key":"12084_CR44","first-page":"2063","volume":"8","author":"D Ranjith","year":"2019","unstructured":"Ranjith, D. & Ravikumar, C. SwissADME predictions of pharmacokinetics and drug-likeness properties of small molecules present in Ipomoea mauritiana Jacq. J. Pharmacogn. Phytochem. 8, 2063\u20132073 (2019).","journal-title":"J. Pharmacogn. Phytochem."},{"key":"12084_CR45","doi-asserted-by":"crossref","unstructured":"Li, R., Luo, P., Guo, Y., He, Y. & Wang, C. Clinical features, treatment, and prognosis of SGLT2 inhibitors induced acute pancreatitis. Expert Opin. Drug Saf. 1\u20135 (2024).","DOI":"10.1080\/14740338.2024.2396387"},{"key":"12084_CR46","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.cimid.2019.03.007","volume":"64","author":"B Ahmad","year":"2019","unstructured":"Ahmad, B. et al. Comprehensive investigations on anti-leishmanial potentials of Euphorbia wallichii root extract and its effects on membrane permeability and apoptosis. Comp. Immunol. Microbiol. Infect. Dis. 64, 138\u2013145 (2019).","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"12084_CR47","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.3390\/pathogens11121424","volume":"11","author":"O Hayat","year":"2022","unstructured":"Hayat, O. et al. A broad spectrum antiparasitic activity of organotin (IV) derivatives and its untargeted proteomic profiling using Leishmania donovani. Pathogens 11, 1424 (2022).","journal-title":"Pathogens"},{"key":"12084_CR48","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55\u201363 (1983).","journal-title":"J. Immunol. Methods"},{"key":"12084_CR49","unstructured":"Cheng, Y. et al. The investigation of Nf\u03bab inhibitors to block cell proliferation in OSCC cells lines. Curr. Med. Chem. (2024)."},{"key":"12084_CR50","doi-asserted-by":"crossref","unstructured":"Nadhman, A. et al. Visible-light-responsive ZnCuO nanoparticles: Benign photodynamic killers of infectious protozoans. Int. J. Nanomed. 6891\u20136903 (2015).","DOI":"10.2147\/IJN.S91666"},{"key":"12084_CR51","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.exppara.2013.10.011","volume":"135","author":"A Sardar","year":"2013","unstructured":"Sardar, A. et al. Spinigerin induces apoptotic like cell death in a caspase independent manner in Leishmania donovani. Exp. Parasitol. 135, 715\u2013725 (2013).","journal-title":"Exp. Parasitol."},{"key":"12084_CR52","doi-asserted-by":"publisher","first-page":"5843","DOI":"10.3390\/molecules26195843","volume":"26","author":"S Mehwish","year":"2021","unstructured":"Mehwish, S. et al. Bioflavonoid-induced apoptosis and DNA damage in amastigotes and promastigotes of Leishmania donovani: Deciphering the mode of action. Molecules 26, 5843 (2021).","journal-title":"Molecules"},{"key":"12084_CR53","first-page":"81","volume":"62","author":"R Gandhidasan","year":"1991","unstructured":"Gandhidasan, R., Thamaraichelvan, A. & Baburaj, S. Anti inflammatory action of Lannea coromandelica by HRBC membrane stabilization. Fitoterapia 62, 81\u201383 (1991).","journal-title":"Fitoterapia"},{"key":"12084_CR54","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0367-326X(99)00030-1","volume":"70","author":"U Shinde","year":"1999","unstructured":"Shinde, U. et al. Membrane stabilizing activity\u2014a possible mechanism of action for the anti-inflammatory activity of Cedrus deodara wood oil. Fitoterapia 70, 251\u2013257 (1999).","journal-title":"Fitoterapia"},{"key":"12084_CR55","first-page":"1759","volume":"7","author":"S Heendeniya","year":"2018","unstructured":"Heendeniya, S., Ratnasooriya, W. & Pathirana, R. In vitro investigation of anti-inflammatory activity and evaluation of phytochemical profile of Syzygium caryophyllatum. J. Pharmacogn. Phytochem. 7, 1759\u20131763 (2018).","journal-title":"J. Pharmacogn. Phytochem."},{"key":"12084_CR56","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00044-018-2133-9","volume":"27","author":"A-N El-Shorbagi","year":"2018","unstructured":"El-Shorbagi, A.-N. et al. Bis-(5-substituted-2-thiono-1, 3, 5-thiadiazinan-3-yl) butane as a scaffold of anti-proliferative activity, blended by a multicomponent process. Med. Chem. Res. 27, 1103\u20131110 (2018).","journal-title":"Med. Chem. Res."},{"key":"12084_CR57","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/1521-4184(20009)333:9<281::AID-ARDP281>3.0.CO;2-E","volume":"333","author":"AN El-Shorbagi","year":"2000","unstructured":"El-Shorbagi, A. N. New Tetrahydro-2H-1, 3, 5-thiadiazine-2-thione derivatives as potential antimicrobial agents. Archiv der Pharm. Int. J. Pharm. Med. Chem. 333, 281\u2013286 (2000).","journal-title":"Archiv der Pharm. Int. J. Pharm. Med. Chem."},{"key":"12084_CR58","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2174\/1573406411006030144","volume":"6","author":"MH Semreen","year":"2010","unstructured":"Semreen, M. H., El-Shorbagi, A.-N., Al-Tel, T. H. & Alsalahat, I. M. Targeting \u03b3-aminobutyric acid (GABA) carriers to the brain: Potential relevance as antiepileptic pro-drugs. Med. Chem. 6, 144\u2013149 (2010).","journal-title":"Med. Chem."},{"key":"12084_CR59","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.1021\/jf0202436","volume":"50","author":"CB Vicentini","year":"2002","unstructured":"Vicentini, C. B., Forlani, G., Manfrini, M., Romagnoli, C. & Mares, D. Development of new fungicides against Magnaporthe grisea: Synthesis and biological activity of pyrazolo [3, 4-d][1, 3] thiazine, pyrazolo [1, 5-c][1, 3, 5] thiadiazine, and pyrazolo [3, 4-d] pyrimidine derivatives. J. Agric. Food Chem. 50, 4839\u20134845 (2002).","journal-title":"J. Agric. Food Chem."},{"key":"12084_CR60","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.bmcl.2005.11.060","volume":"16","author":"J Coro","year":"2006","unstructured":"Coro, J. et al. Alkyl-linked bis-THTT derivatives as potent in vitro trypanocidal agents. Bioorg. Med. Chem. Lett. 16, 1312\u20131315 (2006).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"12084_CR61","doi-asserted-by":"publisher","first-page":"4369","DOI":"10.1016\/S0968-0896(03)00480-2","volume":"11","author":"D Katiyar","year":"2003","unstructured":"Katiyar, D. et al. Synthesis and antimycobacterial activity of 3, 5-disubstituted thiadiazine thiones. Bioorg. Med. Chem. 11, 4369\u20134375 (2003).","journal-title":"Bioorg. Med. Chem."},{"key":"12084_CR62","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1016\/j.bmc.2005.03.009","volume":"13","author":"J Coro","year":"2005","unstructured":"Coro, J. et al. Synthesis and antiprotozoan evaluation of new alkyl-linked bis (2-thioxo-[1, 3, 5] thiadiazinan-3-yl) carboxylic acids. Bioorg. Med. Chem. 13, 3413\u20133421 (2005).","journal-title":"Bioorg. Med. Chem."},{"key":"12084_CR63","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1016\/j.bmcl.2007.05.020","volume":"17","author":"X Ji","year":"2007","unstructured":"Ji, X. et al. Preparation of 1, 3, 5-thiadiazine-2-thione derivatives of chitosan and their potential antioxidant activity in vitro. Bioorg. Med. Chem. Lett. 17, 4275\u20134279 (2007).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"12084_CR64","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1021\/jf0500029","volume":"53","author":"CB Vicentini","year":"2005","unstructured":"Vicentini, C. B. et al. Pyrazole derivatives as photosynthetic electron transport inhibitors: New leads and structure\u2212 activity relationship. J. Agric. Food Chem. 53, 3848\u20133855 (2005).","journal-title":"J. Agric. Food Chem."},{"key":"12084_CR65","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1021\/jm0303812","volume":"47","author":"P Ettmayer","year":"2004","unstructured":"Ettmayer, P., Amidon, G. L., Clement, B. & Testa, B. Lessons learned from marketed and investigational prodrugs. J. Med. Chem. 47, 2393\u20132404 (2004).","journal-title":"J. Med. Chem."},{"key":"12084_CR66","doi-asserted-by":"publisher","first-page":"20228136","DOI":"10.1515\/gps-2022-8136","volume":"12","author":"H Ali","year":"2023","unstructured":"Ali, H. et al. Synthesis, characterization, anticancer, anti-inflammatory activities, and docking studies of 3, 5-disubstituted thiadiazine-2-thiones. Green Process. Synth. 12, 20228136 (2023).","journal-title":"Green Process. Synth."},{"key":"12084_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13205-019-1826-1","volume":"9","author":"S Mehwish","year":"2019","unstructured":"Mehwish, S. et al. Natural compounds from plants controlling leishmanial growth via DNA damage and inhibiting trypanothione reductase and trypanothione synthetase: An in vitro and in silico approach. 3 Biotech. 9, 1\u201314 (2019).","journal-title":"3 Biotech."},{"key":"12084_CR68","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2217\/fmb-2021-0094","volume":"17","author":"D Ramu","year":"2022","unstructured":"Ramu, D. & Singh, S. Potential molecular targets of Leishmania pathways in developing novel antileishmanials. Fut. Microbiol. 17, 41\u201357 (2022).","journal-title":"Fut. Microbiol."},{"key":"12084_CR69","doi-asserted-by":"publisher","first-page":"6928","DOI":"10.1038\/s41598-023-34124-9","volume":"13","author":"JG Schirmann","year":"2023","unstructured":"Schirmann, J. G. et al. In-vitro biological evaluation of 3, 3\u2032, 5, 5\u2032-tetramethoxy-biphenyl-4, 4\u2032-diol and molecular docking studies on trypanothione reductase and Gp63 from Leishmania amazonensis demonstrated anti-leishmania potential. Sci. Rep. 13, 6928 (2023).","journal-title":"Sci. Rep."},{"key":"12084_CR70","doi-asserted-by":"publisher","first-page":"10374","DOI":"10.1080\/07391102.2023.2256879","volume":"42","author":"H Khan","year":"2024","unstructured":"Khan, H. et al. Investigating the role of Sterol C24-Methyl transferase mutation on drug resistance in leishmaniasis and identifying potential inhibitors. J. Biomol. Struct. Dyn. 42, 10374\u201310387 (2024).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"12084_CR71","doi-asserted-by":"publisher","first-page":"129068","DOI":"10.1016\/j.bmcl.2022.129068","volume":"79","author":"N Arshad","year":"2023","unstructured":"Arshad, N. et al. Highly potent anti-inflammatory, analgesic and antioxidant activities of 3, 5-disubstituted tetrahydro-2H-1, 3, 5-thiadiazine thiones. Bioorg. Med. Chem. Lett. 79, 129068 (2023).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"12084_CR72","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ejmech.2016.02.036","volume":"113","author":"B Sever","year":"2016","unstructured":"Sever, B. et al. Indomethacin based new triazolothiadiazine derivatives: Synthesis, evaluation of their anticancer effects on T98 human glioma cell line related to COX-2 inhibition and docking studies. Eur. J. Med. Chem. 113, 179\u2013186 (2016).","journal-title":"Eur. J. Med. Chem."},{"key":"12084_CR73","doi-asserted-by":"crossref","unstructured":"Eswaramoorthy, R., Hailekiros, H., Kedir, F. & Endale, M. In silico molecular docking, DFT analysis and ADMET studies of carbazole alkaloid and coumarins from roots of Clausena anisata: A potent inhibitor for quorum sensing. Adv. Appl. Bioinf. Chem. 13\u201324 (2021).","DOI":"10.2147\/AABC.S290912"},{"key":"12084_CR74","doi-asserted-by":"publisher","first-page":"106774","DOI":"10.1016\/j.phrs.2023.106774","volume":"191","author":"R Roskoski Jr","year":"2023","unstructured":"Roskoski, R. Jr. Rule of five violations among the FDA-approved small molecule protein kinase inhibitors. Pharmacol. Res. 191, 106774 (2023).","journal-title":"Pharmacol. Res."},{"key":"12084_CR75","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.2174\/1570180820666230224112505","volume":"21","author":"N Lohit","year":"2024","unstructured":"Lohit, N. et al. Description and in silico ADME studies of US-FDA approved drugs or drugs under clinical trial which violate the Lipinski\u2019s rule of 5. Lett. Drug Des. Discov. 21, 1334\u20131358 (2024).","journal-title":"Lett. Drug Des. Discov."},{"key":"12084_CR76","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.addr.2016.05.007","volume":"101","author":"LZ Benet","year":"2016","unstructured":"Benet, L. Z., Hosey, C. M., Ursu, O. & Oprea, T. I. BDDCS, the rule of 5 and drugability. Adv. Drug Deliv. Rev. 101, 89\u201398 (2016).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"12084_CR77","doi-asserted-by":"publisher","first-page":"8588","DOI":"10.1080\/07391102.2023.2246589","volume":"42","author":"A Shtaiwi","year":"2024","unstructured":"Shtaiwi, A. Thiadiazine-thiones as inhibitors of leishmania pteridine reductase (PTR1) target: Investigations and in silico approach. J. Biomol. Struct. Dyn. 42, 8588\u20138597 (2024).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"12084_CR78","doi-asserted-by":"publisher","first-page":"7612","DOI":"10.3390\/molecules17077612","volume":"17","author":"H Rodr\u00edguez","year":"2012","unstructured":"Rodr\u00edguez, H., Su\u00e1rez, M. & Albericio, F. Thiadiazines, N, N-heterocycles of biological relevance. Molecules 17, 7612\u20137628 (2012).","journal-title":"Molecules"},{"key":"12084_CR79","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1016\/j.bmcl.2018.07.045","volume":"28","author":"N Arshad","year":"2018","unstructured":"Arshad, N. et al. New series of 3, 5-disubstituted tetrahydro-2H-1, 3, 5-thiadiazine thione (THTT) derivatives: Synthesis and potent antileishmanial activity. Bioorg. Med. Chem. Lett. 28, 3251\u20133254 (2018).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"12084_CR80","doi-asserted-by":"publisher","first-page":"e7581","DOI":"10.7717\/peerj.7581","volume":"7","author":"J Yan","year":"2019","unstructured":"Yan, J. et al. Design, synthesis and antimicrobial activities of novel 1, 3, 5-thiadiazine-2-thione derivatives containing a 1, 3, 4-thiadiazole group. PeerJ 7, e7581 (2019).","journal-title":"PeerJ"},{"key":"12084_CR81","doi-asserted-by":"publisher","first-page":"7758","DOI":"10.1080\/07391102.2023.2245480","volume":"42","author":"Tamanna","year":"2024","unstructured":"Tamanna, et al. Thiadiazine thione derivatives as anti-leishmanial agents: Synthesis, biological evaluation, structure activity relationship, ADMET, molecular docking and molecular dynamics simulation studies. J. Biomol. Struct. Dyn. 42, 7758\u20137772 (2024).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"12084_CR82","unstructured":"J\u00e1come, O. & Poleth, M. Chemical Characterization of Six Thiadiazine Compounds with Antimalarial Activity and their Cross-Reactivity in the Humoral Response. Universidad de Investigaci\u00f3n de Tecnolog\u00eda Experimental Yachay, (2021)."},{"key":"12084_CR83","first-page":"773","volume":"34","author":"N Arshad","year":"2021","unstructured":"Arshad, N. et al. Antiproliferative activity of 3, 5-disubstituted tetrahydro-2H-1, 3, 5-thiadiazine thione (THTT) derivatives and evaluation as potential prodrug. Pak. J. Pharm. Sci. 34, 773 (2021).","journal-title":"Pak. J. Pharm. Sci."},{"key":"12084_CR84","first-page":"135","volume":"6","author":"R Cherdtrakulkiat","year":"2016","unstructured":"Cherdtrakulkiat, R. et al. Derivatives (halogen, nitro and amino) of 8-hydroxyquinoline with highly potent antimicrobial and antioxidant activities. Biochem. Biophys. Rep. 6, 135\u2013141 (2016).","journal-title":"Biochem. Biophys. Rep."},{"key":"12084_CR85","first-page":"789","volume":"64","author":"IA Bukhari","year":"2013","unstructured":"Bukhari, I. A., Alhumayyd, M., Mahesar, A. & Gilani, A. The analgesic and anticonvulsant effects of piperine in mice. J. Physiol. Pharmacol. 64, 789 (2013).","journal-title":"J. Physiol. Pharmacol."},{"key":"12084_CR86","first-page":"256","volume":"2","author":"R Chaitanya","year":"2011","unstructured":"Chaitanya, R., Sandhya, S., David, B., Vinod, K. & Murali, S. HRBC membrane stabilizing property of roor, stem and leaf of glochidion velutinum. Int. J. Res. Pharm. Biomed. Sci. 2, 256\u2013259 (2011).","journal-title":"Int. J. Res. Pharm. Biomed. Sci."},{"key":"12084_CR87","doi-asserted-by":"publisher","first-page":"S178","DOI":"10.1016\/S2221-1691(12)60154-3","volume":"2","author":"S Chandra","year":"2012","unstructured":"Chandra, S., Chatterjee, P., Dey, P. & Bhattacharya, S. Evaluation of in vitro anti-inflammatory activity of coffee against the denaturation of protein. Asian Pac. J. Trop. Biomed. 2, S178\u2013S180 (2012).","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"12084_CR88","unstructured":"Paridhavi, M. & Agrawal, S. Safety evaluation of a polyherbal formulation, Zuroor-E\u2013Qula. (2007)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12084-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12084-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12084-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T12:56:32Z","timestamp":1757336192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12084-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,2]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12084"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-12084-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,2]]},"assertion":[{"value":"14 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the research ethics committee of the Department of Biotechnology, Abdul Wali Khan University Mardan, under the protocol number (AWKUM\/ BIOTECH\/2022\/2930).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28246"}}